#OrganizationalReform

Kobayashi Pharmaceutical provides a detailed report on the progress of recurrence prevention measures for quality issues related to red yeast rice products, promoting strengthening of a quality and safety-first system and organizational culture reform.

SUBARU will implement organizational reforms and executive changes effective April 1, 2026 and June 2026. Through the establishment of new divisions and appointment of new executives, the company aims to strengthen the execution system.

Established the Culture Transformation Lab as of February 1, 2026, with Executive Officer Masayuki Minai's position change and Shinichi Kishida appointed as Chief of the Culture Transformation Lab in personnel changes.